RecruitingNCT06748365

Serum Ferritin and Prognosis of DKA

Role of Ferritin in the Clinical Presentation and Short-Term Prognosis of Diabetic Ketoacidosis


Sponsor

Sohag University

Enrollment

100 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

the aim of this study is to: evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value in predicting short-term outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • \-
  • All patients with DKA :
  • Adult Aged 18 years old or older .
  • Type 1 DM , type 2 DM
  • Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <18 mEq/L,

Exclusion Criteria9

  • Patients age less than 18 years old
  • Iron deficiency anemia and iron overload
  • Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease
  • Acute and chronic infections, including bacterial, viral, and fungal infections
  • Pt presented with other acute complication (MI,stroke)
  • CKD patients
  • Patients with chronic liver diseases
  • Patients with malignancy
  • Pregnant women.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Sohag university Hospitals

Sohag, Sohag Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06748365


Related Trials